Drug
Secretin human clinical trials
Also written Synthetic Human Secretin and RG1068.
Includes 1 study of Secretin human acetate.
- studies test it
- 17
- open now
- 0
- in phase 3
- 6
- first study started
- 2002
How studies write it
Studies that test it under each name
Development codes
Other names
Studies by the year they started
17 studies that test it; most in 2008 (4)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 6
- Phase 2
- 5
- Phase 3
- 6
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 12
Repligen Corporation (3) · Massachusetts General Hospital (3) · Mayo Clinic (2) · ChiRhoClin, Inc. (2) · Columbia University (2) · Indiana University School of Medicine (1) · Turku University Hospital (1) · Elizabeth Hecht (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses secretin human is read from its arms, and is right about nine times in ten.
Testing it · 17
- Recurrent Abdominal Pain and Exocrine Pancreatic InsufficiencyTerminatedPhase 3Orlando Health, Inc.NCT04231279Written as synthetic human secretin
- Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive DisorderCompletedPhase 2Indiana University School of MedicineNCT00216294Written as RG1068 (Synthetic Human Secretin)
- Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor ConspicuityWithdrawnEarly Phase 1University Hospitals Cleveland Medical CenterNCT01371240Written as Secretin Synthetic Human (RG1068)
- Effect of Secretin in Functional Dyspepsia and Healthy SubjectsCompletedPhase 1/2Mayo ClinicNCT03617861Written as Human Secretin
- Secretin Activates Human Brown Fat and Induces Satiation.CompletedPhase 2/3Turku University HospitalNCT03290846Written as Secretin Human
- Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic PatientsCompletedNot applicableElizabeth HechtNCT01094561Written as Synthetic Human Secretin
- Secretin Infusion for Pain Due to Chronic PancreatitisCompletedPhase 1/2ChiRhoClin, Inc.NCT01265875Written as Human Secretin
- Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following SurgeryWithdrawnNot applicableColumbia UniversityNCT01094535Written as Synthetic Human Secretin
- Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic AdenocarcinomaTerminatedPhase 1/2Mayo ClinicNCT00587132Written as Synthetic Human Secretin
- Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine InsufficiencyWithdrawnNot applicableColumbia UniversityNCT01094600Written as Synthetic Human Secretin
- A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA MarkersCompletedPhase 3ChiRhoClin, Inc.NCT01087801Written as ChiRhoStim
- Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the PancreasCompletedPhase 3Repligen CorporationNCT00660335Written as RG1068 (synthetic human secretin)
- Secretin Enhanced Multidetector CT Pancreatography for Evaluation of Known or Suspected Chronic PancreatitisTerminatedPhase 1Massachusetts General HospitalNCT00620919Written as RG1068 (Synthetic Human Secretin)
- Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric PopulationTerminatedPhase 1Massachusetts General HospitalNCT00621283Written as RG1068 (Synthetic Human Secretin)
- Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the PancreasTerminatedPhase 1Massachusetts General HospitalNCT00621556Written as RG1068 (Synthetic Human Secretin)
- Synthetic Human Secretin in Children With Autism and Gastrointestinal DysfunctionTerminatedPhase 3Repligen CorporationNCT00036231Written as RG1068 (Synthetic Human Secretin)
- Synthetic Human Secretin in Children With AutismCompletedPhase 3Repligen CorporationNCT00036244Written as RG1068 (Synthetic Human Secretin)
Codes
What other systems call secretin human · ClinicalTrials.gg INT015939
- UNII (FDA) A0426J905JSECRETIN HUMANOne source FDA
- RxNorm 606396One source FDA
- NCI Thesaurus C47713Secretin HumanOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | A0426J905J | SECRETIN HUMAN | One source FDA |
| RxNorm | 606396 | — | One source FDA |
| NCI Thesaurus | C47713 | Secretin Human | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.